These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 18455252)

  • 21. Hypofractionated stereotactic radiotherapy for the treatment of brain metastases.
    Kwon AK; Dibiase SJ; Wang B; Hughes SL; Milcarek B; Zhu Y
    Cancer; 2009 Feb; 115(4):890-8. PubMed ID: 19132728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas.
    Paek SH; Downes MB; Bednarz G; Keane WM; Werner-Wasik M; Curran WJ; Andrews DW
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):795-808. PubMed ID: 15708259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does intensity-modulated stereotactic radiotherapy achieve superior target conformity than conventional stereotactic radiotherapy in different intracranial tumours?
    Sharma SD; Jalali R; Phurailatpam RD; Gupta T
    Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):408-16. PubMed ID: 19268555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic radiotherapy of meningiomas: symptomatology, acute and late toxicity.
    Henzel M; Gross MW; Hamm K; Surber G; Kleinert G; Failing T; Strassmann G; Engenhart-Cabillic R
    Strahlenther Onkol; 2006 Jul; 182(7):382-8. PubMed ID: 16826356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.
    Combs SE; Thilmann C; Edler L; Debus J; Schulz-Ertner D
    J Clin Oncol; 2005 Dec; 23(34):8863-9. PubMed ID: 16314646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
    Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in treatment techniques and time/dose schedules in external radiation therapy of brain tumours in childhood.
    Kortmann RD; Timmermann B; Becker G; Kühl J; Bamberg M
    Klin Padiatr; 1998; 210(4):220-6. PubMed ID: 9743956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reirradiation of recurrent WHO grade III astrocytomas using fractionated stereotactic radiotherapy (FSRT).
    Combs SE; Gutwein S; Thilmann C; Debus J; Schulz-Ertner D
    Strahlenther Onkol; 2005 Dec; 181(12):768-73. PubMed ID: 16362786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.
    Beauchesne PD; Taillandier L; Bernier V; Carnin C
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):171-5. PubMed ID: 19352662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractionated stereotactic radiotherapy in the treatment of exclusive cavernous sinus meningioma: functional outcome, local control, and tolerance.
    Brell M; Villà S; Teixidor P; Lucas A; Ferrán E; Marín S; Acebes JJ
    Surg Neurol; 2006 Jan; 65(1):28-33; discussion 33-4. PubMed ID: 16378847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma.
    Chen HH; Tsai ST; Wang MS; Wu YH; Hsueh WT; Yang MW; Yeh IC; Lin JC
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1408-14. PubMed ID: 17126207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractionated stereotactic radiation therapy in the management of primary oligodendroglioma and oligoastrocytoma.
    Combs SE; Schulz-Ertner D; Thilmann C; Edler L; Debus J
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):797-802. PubMed ID: 15936562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.
    Combs SE; Volk S; Schulz-Ertner D; Huber PE; Thilmann C; Debus J
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):75-81. PubMed ID: 16111574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR: clinical expierence.
    Leonardi MA; Lumenta CB
    Minim Invasive Neurosurg; 2002 Dec; 45(4):201-7. PubMed ID: 12494354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immediate postoperative radiotherapy or "watch and wait" in the management of adult low-grade glioma?
    Kortmann RD; Jeremic B; Weller M; Lutterbach J; Paulsen F; Bamberg M
    Strahlenther Onkol; 2004 Jul; 180(7):408-18. PubMed ID: 15241528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment accuracy of fractionated stereotactic radiotherapy.
    Kumar S; Burke K; Nalder C; Jarrett P; Mubata C; A'hern R; Humphreys M; Bidmead M; Brada M
    Radiother Oncol; 2005 Jan; 74(1):53-9. PubMed ID: 15683670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.
    King CR; Brooks JD; Gill H; Pawlicki T; Cotrutz C; Presti JC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1043-8. PubMed ID: 18755555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma.
    Choi BO; Jang HS; Kang KM; Lee SW; Kang YN; Chai GY; Choi IB
    Jpn J Clin Oncol; 2006 Mar; 36(3):154-8. PubMed ID: 16520355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Volumetric changes following 125I interstitial brachytherapy of gliomas].
    Julow J; Viola A; Major T; Mangel L; Bajzik G; Repa I; Sági S; Valálik I; Emri M; Trón L; Németh G
    Ideggyogy Sz; 2005 Mar; 58(3-4):120-32. PubMed ID: 15887415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.